10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001638833-21-000136`
Period End Date	20210630
Filing Date	20210804
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	sgry-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 99 Income Statement 122 Cash Flow Statement 80 Stockholders Equity 43 Comprehensive Income 22

Balance Sheet 99 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property and equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$189.30M	USD	Point-in-time
Accumulated depreciation on property and equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$231.00M	USD	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$464.80M	USD	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$317.90M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$382.20M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$374.90M	USD	Point-in-time
Inventories	`InventoryNet`	$56.40M	USD	Point-in-time
Inventories	`InventoryNet`	$57.30M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$434.50M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.60M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$28.30M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.60M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.40M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$952.90M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$801.50M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $231.0 and $189.3, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$543.90M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $231.0 and $189.3, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$544.60M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.51B	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.53B	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$90.20M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$90.30M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	50.46M	shares	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$318.80M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$310.10M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	82.48M	shares	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$129.80M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$124.80M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	82.48M	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$51.10M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$27.00M	USD	Point-in-time
Total assets	`Assets`	$5.41B	USD	Point-in-time
Total assets	`Assets`	$5.62B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$109.10M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$100.20M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$65.40M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$75.60M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$78.60M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$109.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$199.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$217.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$69.60M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$64.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$531.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$556.80M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.79B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.79B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$300.90M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$310.80M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$139.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$151.70M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$314.70M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$312.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$306.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$321.00M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - $ and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - $ and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$434.50M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 82,478,580 and 50,461,706, respectively	`CommonStockValueOutstanding`	$800.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 82,478,580 and 50,461,706, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$607.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.30B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-61.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-54.40M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-431.80M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-479.70M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$765.10M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$115.60M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$762.20M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$766.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.62B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.41B	USD	Point-in-time

Income Statement 122 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.06B	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$815.70M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$374.70M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$543.30M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$256.50M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$307.00M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$116.10M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$155.30M	USD	1 Quarter
Supplies	`SuppliesExpense`	$110.10M	USD	1 Quarter
Supplies	`SuppliesExpense`	$304.80M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$157.50M	USD	1 Quarter
Supplies	`SuppliesExpense`	$239.40M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$112.90M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$45.30M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$92.10M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$57.40M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$22.60M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.50M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$42.80M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$45.40M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$63.80M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$26.30M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$54.70M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$32.20M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$425.00M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$833.90M	USD	2 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$319.30M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$685.50M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$51.30M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$25.30M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$24.50M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$48.10M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$45.20M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$23.40M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$50.90M	USD	2 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.50M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$5.60M	USD	2 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$4.50M	USD	2 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$3.00M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.90M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-100.00K	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-6.40M	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$9.20M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$4.90M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$14.50M	USD	2 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$10.40M	USD	2 Qtrs
Grant funds	`GrantRevenue`	$43.10M	USD	1 Quarter
Grant funds	`GrantRevenue`	$43.10M	USD	2 Qtrs
Grant funds	`GrantRevenue`	$4.90M	USD	1 Quarter
Grant funds	`GrantRevenue`	$20.00M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-46.00M	USD	Annual
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-1.20M	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-1.20M	USD	2 Qtrs
Other income	`OtherNonrecurringIncomeExpense`	$-2.80M	USD	2 Qtrs
Other income	`OtherNonrecurringIncomeExpense`	$-2.80M	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	$-200.00K	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	$-1.70M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$747.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$330.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$483.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$931.90M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$59.50M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$44.70M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$68.20M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$123.80M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-106.70M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-96.30M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-53.40M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-49.20M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-4.50M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$6.10M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-28.10M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$17.10M	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-2.50M	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-600.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-15.80M	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-2.70M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-12.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$19.60M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$8.80M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.90M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$47.70M	USD	2 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$28.60M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$35.70M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$67.50M	USD	2 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-47.90M	USD	2 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-60.00M	USD	2 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-26.90M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-32.50M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$10.30M	USD	2 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$9.70M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$19.20M	USD	2 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	-	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.90M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-79.20M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.20M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-42.20M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.86	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-1.63	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.39	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.94	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.86	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.39	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.94	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-1.63	USD	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	69.27M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	62.06M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.84M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.66M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	62.06M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.84M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.66M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	69.27M	shares	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-12.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$19.60M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$8.80M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.90M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$45.20M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$23.40M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$50.90M	USD	2 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-2.20M	USD	2 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-5.70M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.10M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$6.90M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$9.30M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$3.40M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.90M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-100.00K	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-6.40M	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-16.40M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-3.20M	USD	2 Qtrs
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$400.00K	USD	2 Qtrs
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$200.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$20.10M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$20.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-16.30M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.10M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$124.70M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-28.80M	USD	2 Qtrs
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	$32.20M	USD	2 Qtrs
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	$4.00M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-22.20M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-5.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$211.10M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$52.50M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.90M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$15.20M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$12.40M	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$9.40M	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$2.50M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-400.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-40.70M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.50M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$309.40M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$182.80M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$288.20M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$283.10M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$8.70M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$6.50M	USD	2 Qtrs
Payment of premium on debt extinguishment	`PaymentsOfDebtExtinguishmentCosts`	-	USD	2 Qtrs
Payment of premium on debt extinguishment	`PaymentsOfDebtExtinguishmentCosts`	$2.40M	USD	2 Qtrs
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	$260.90M	USD	2 Qtrs
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	2 Qtrs
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	$12.70M	USD	2 Qtrs
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	2 Qtrs
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$5.10M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$63.40M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$51.70M	USD	2 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromMinorityShareholders`	$3.40M	USD	2 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$1.90M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-300.00K	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-10.90M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$45.00M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$134.80M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$146.60M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$233.60M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$326.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$464.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$326.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$464.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time

Stockholders Equity 43 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	82.48M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$100.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-13.90M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-4.90M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-9.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.70M	USD	1 Quarter
Preferred share conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$439.70M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.50M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.70M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.30M	USD	1 Quarter
Equity offering	`StockIssuedDuringPeriodValueNewIssues`	$248.30M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.60M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-17.90M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$200.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$7.30M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$5.60M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$2.30M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$1.70M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$700.00K	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.90M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.80M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$22.30M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$14.90M	USD	1 Quarter
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	82.48M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time

Comprehensive Income 22 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-12.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$19.60M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$8.80M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.90M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.60M	USD	2 Qtrs
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-17.90M	USD	2 Qtrs
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$200.00K	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$7.30M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.40M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-30.20M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$9.00M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$26.20M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$35.70M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$28.60M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$47.70M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$67.50M	USD	2 Qtrs
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-41.30M	USD	2 Qtrs
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-77.90M	USD	2 Qtrs
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-26.70M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-25.20M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.